BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27576480)

  • 1. HLA and Delayed Drug-Induced Hypersensitivity.
    Sousa-Pinto B; Correia C; Gomes L; Gil-Mata S; Araújo L; Correia O; Delgado L
    Int Arch Allergy Immunol; 2016; 170(3):163-79. PubMed ID: 27576480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-mediated hypersensitivity reactions to drugs.
    Pavlos R; Mallal S; Ostrov D; Buus S; Metushi I; Peters B; Phillips E
    Annu Rev Med; 2015; 66():439-54. PubMed ID: 25386935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA alleles and drug hypersensitivity reactions.
    Profaizer T; Eckels D
    Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.
    Cheng CY; Su SC; Chen CH; Chen WL; Deng ST; Chung WH
    J Immunol Res; 2014; 2014():565320. PubMed ID: 24901010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity.
    Guéant JL; Guéant-Rodriguez RM; Gastin IA; Cornejo-García JA; Viola M; Barbaud A; Mertes PM; Blanca M; Romano A
    Curr Pharm Des; 2008; 14(27):2770-7. PubMed ID: 18991696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic predispositions in drug allergy: the role of HLA].
    Bergmann MM; Villard J; Caubet JC
    Rev Med Suisse; 2014 Apr; 10(426):864-8. PubMed ID: 24834645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.
    Michels AW; Ostrov DA
    J Allergy Clin Immunol; 2015 Aug; 136(2):252-7. PubMed ID: 26254052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
    Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
    Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
    Yeo SI
    Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
    White KD; Chung WH; Hung SI; Mallal S; Phillips EJ
    J Allergy Clin Immunol; 2015 Aug; 136(2):219-34; quiz 235. PubMed ID: 26254049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and pharmacogenetics of drug hypersensitivity.
    Pavlos R; Mallal S; Phillips E
    Pharmacogenomics; 2012 Aug; 13(11):1285-306. PubMed ID: 22920398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions.
    Illing PT; Mifsud NA; Purcell AW
    Curr Opin Immunol; 2016 Oct; 42():31-40. PubMed ID: 27261882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
    Pirmohamed M; Ostrov DA; Park BK
    J Allergy Clin Immunol; 2015 Aug; 136(2):236-44. PubMed ID: 26254050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
    Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
    J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.